A Comprehensive Survey Of The Governmental Hospitals Conducted In Cooperation Between The MoPH And T

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01FG01	STIVANT	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	14,719,570 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,800,115 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 100mg/10ml	100mg/10ml	Injectable solution	47,779,251 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 500mg/50ml	500mg/50ml	Injectable solution	218,656,548 L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	748,160,090 L.L
L01FX04	YERVOY	BioTech	Ipilimumab - 50mg/10ml	50mg/10ml	Injectable solution	332,262,937 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable lyophilised powder for solution+diluent	52,297,174 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	37,110,724 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,038,213 L.L
L01FX18	RYBREVANT	BioTech	Amivantamab - 350mg	350mg	Injectable concentrate for solution	135,818,621 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	54,382,728 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	35,423,371 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 4000U Anti-Xa/0.4ml	4000U Anti-Xa/0.4ml	Injectable solution	753,832 L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 4,000U Anti-Xa/0.4ml	4,000U Anti-Xa/0.4ml	Injectable solution	755,239 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 4000IU Anti-XA/0.4ml	4000IU Anti-XA/0.4ml	Injectable solution	755,239 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 4000IU Anti-XA/0.4ml	4000IU Anti-XA/0.4ml	Injectable solution	2,150,148 L.L
B01AB05	ENOXAPARIN LEDRAXEN	BioTech	Enoxaparin sodium - 4000UI (40mg)/0.4ml	4000UI (40mg)/0.4ml	Injectable solution	841,245 L.L
B01AB05	HEPAXANE 4000IU	BioTech	Enoxaparin sodium - 40mg/0.4ml	40mg/0.4ml	Injectable solution	4,063,780 L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	51,255,093 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 4,000UI (40mg)/0.4ml	4,000UI (40mg)/0.4ml	Injectable solution	886,936 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
B01AB05	PARINOX 40	BioTech	Enoxaparin sodium - 4000IU (40mg)/0.4ml	4000IU (40mg)/0.4ml	Injectable solution	358,358 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 8mg/0.07ml	8mg/0.07ml	Injectable solution	75,348,607 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 8000U Anti-Xa/0.8ml	8000U Anti-Xa/0.8ml	Injectable solution	1,025,160 L.L
S01LA06	BEOVU	BioTech	Brolucizumab - 120mg/ml	120mg/ml	Injectable solution	68,669,378 L.L

اجراء مسح شامل للمستشفيات الحكومية بالتعاون بين وزارة الصحة العامة والتفتيش المركزي